Traditional Chinese Medicine Improves Outcomes in HFrEF
In the randomized trial QUEST trial, a traditional Chinese medicine called qiliqiangxin provided significant reductions in CV death and hospitalization on top of guideline-directed therapy in HFrEF.
Medscape Medical News
source https://www.medscape.com/viewarticle/995876?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/995876?src=rss
Comments
Post a Comment